PhRMA Contributes $11.3M To SCHIP Advertising Campaign
Main Category: Medicare / Medicaid / SCHIPAlso Included In: Pharma Industry / Biotech Industry
Article Date: 23 Sep 2008 - 10:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The Pharmaceutical Research and Manufacturers of America has contributed $11.3 million to the advocacy group America's Agenda: Health Care for Kids for advertisements supporting SCHIP expansion, CQ HealthBeat reports. The ads will appear in at least 25 lawmakers' states and congressional districts. The ads do not name SCHIP specifically but commend lawmakers who supported a bill (HR 3963) that would have expanded SCHIP. President Bush vetoed the bill, citing cost concerns (Jansen, CQ HealthBeat, 9/19).
The House in January fell 15 votes short of the two-thirds majority required to override President Bush's veto of the legislation. The bill would have expanded SCHIP to cover 10 million children and increased spending on the program by $35 billion over five years, funded by a 61-cent-per-pack increase of the federal cigarette tax. It also would have limited coverage to children in families with annual incomes below 300% of the federal poverty level (Kaiser Daily Health Policy Report, 1/24).
The ads encourage viewers to contact their lawmakers and tell them to "keep fighting to insure our kids" (CQ HealthBeat, 9/19).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our medicare / medicaid / schip section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/122507.php>
APA
http://www.medicalnewstoday.com/releases/122507.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




